| NCT ID | NCT07030192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Substance Use Disorder (SUD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,181 participants |
| Start Date | 2024-11-23 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,181 participants in total. It began in 2024-11-23 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peer) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and potentially lower mortality rates. This study aims to evaluate how a hospital-implemented ED Peer program can enhance patient support, reduce barriers to care, and provide harm-reduction resources in a person-centred and trauma-informed manner. The study will also validate the outcome and obtain preliminary estimates of the benefits of decreasing patients who leave the ED before completing care.
Eligibility Criteria
Inclusion Criteria: * Emergency Department (ED) patient at Vancouver General Hospital (VGH) * Age 18 years or older * Identified as using substances * Able to receive or decline peer support services during the ED visit Exclusion Criteria: * Under 18 years of age * Does not report substance use
Contact & Investigator
Jessica Moe, MD
PRINCIPAL INVESTIGATOR
University of British Columbia
Frequently Asked Questions
Who can join the NCT07030192 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use Disorder (SUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07030192 currently recruiting?
Yes, NCT07030192 is actively recruiting participants. Contact the research team at cindy.q.liu@ubc.ca for enrollment information.
Where is the NCT07030192 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT07030192 clinical trial?
NCT07030192 is sponsored by University of British Columbia. The principal investigator is Jessica Moe, MD at University of British Columbia. The trial plans to enroll 3,181 participants.